Heterojunction with Photo-Responsive Therapy against Multidrug-Resistant Bacteria for Rapid Sterilization and Improved Burned Wound Healing
- PMID: 41472387
- DOI: 10.1002/adhm.202502842
Heterojunction with Photo-Responsive Therapy against Multidrug-Resistant Bacteria for Rapid Sterilization and Improved Burned Wound Healing
Abstract
As one of the most common forms of skin injuries, skin burns are often accompanied by infection, slow tissue regeneration and severe scar formation, which significantly delay wound healing as well as affect the quality of life. Phototherapy has emerged as a promising alternative to conventional antibiotics in the treatment of infectious burn skin. However, the excessive heat generated by near-infrared (NIR) phototherapy risks causing secondary tissue damage. Herein, we develop a Ti2C3 MXene and copper selenide (CuSe) heterojunctions (M/C HJs) that synergistically produce high reactive oxygen species (ROS) yields and mild hyperthermia (around 50°C) under NIR irradiation while simultaneously overcoming bacterial drug resistance. In vitro antibacterial assays combined with transcriptomic analysis demonstrate that M/C HJs exert potent bactericidal effects with a sterilization rate of exceeding 99% under NIR by targeting the bacterial electron transport chain (ETC) in various pH condition. This disruption simultaneously impairs critical metabolic pathways and energy synthesis while effectively attenuating bacterial resistance mechanisms. In a murine burn infection model, M/C HJs demonstrate remarkable antimicrobial efficacy while concurrently promoting collagen deposition and suppressing hypertrophic scar formation in the wound bed. Therefore, this work opens the new mode of effective integrated treatment of burn wounds, further driving the in-depth study of clinical transformation mechanisms in the future.
Keywords: antibacterial; burn wound; heterojunction; phototherapy; tissue regeneration.
© 2025 Wiley‐VCH GmbH.
References
-
- Y. Wang, J. Beekman, J. Hew, et al., “Burn injury: Challenges and Advances in Burn Wound Healing, Infection, Pain and Scarring,” Advanced Drug Delivery Reviews 123 (2018): 3–17.
-
- D. Church, S. Elsayed, O. Reid, B. Winston, and R. Lindsay, “Burn Wound Infections,” Clinical Microbiology Reviews 19 (2006): 403–434.
-
- M. Asensio, M. Sánchez, B. Galván, et al., “Micafungin At a Standard Dosage of 100 Mg/Day Achieves Adequate Plasma Exposure in Critically Ill Patients with Severe Burn Injuries,” Intensive Care Medicine 41 (2015): 371–372.
-
- J. Earl, J. W. Shupp, and B. Krohmal, “Ethical Justifications for Waiving Informed Consent for a Perianal Swab in Critical Burn Care Research,” The American Journal of Bioethics 24 (2024): 110–113.
-
- E. J. Kelly, M. A. Oliver, B. C. Carney, and J. W. Shupp, “Infection and Burn Injury,” European Burn Journal 3 (2022): 165–179.
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
